home / stock / aqst / aqst news

AQST News and Press, Aquestive Therapeutics Inc.

Stock Information
Company Name: Aquestive Therapeutics Inc.
Stock Symbol: AQST
Market: NASDAQ
Website: aquestive.com
Menu
AQST AQST Quote AQST Short AQST News AQST Articles AQST Message Board
Get AQST Alerts

News, Short Squeeze, Breakout and More Instantly...
AQST - Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

WARREN, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...
AQST - ARS Pharmaceuticals On Track With Neffy Despite Regulatory Hurdles

2024-06-25 14:10:10 ET Summary ARS Pharmaceuticals stock has recovered since the FDA's Complete Response Letter regarding its epinephrine nasal spray, neffy. Despite competition and a delayed market entry, ARS Pharmaceuticals remains ahead with its unique nasal spray, aiming for a...

AQST - Aquestive gains after initial data for allergy candidate

2024-06-25 09:29:33 ET More on Aquestive Therapeutics Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript Aquestive Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation Aquestive Therapeutics: Positive Phase III Data Unlocks Additional C...

AQST - Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm(TM) (epinephrine) Sublingual Film

Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pH Remains on track to complete Anaphylm supportive clinical studies and expects to request pre-NDA meeting with FDA in the third quarter 2024 Continues to anticipate filin...
AQST - Aquestive Therapeutics to join Russell 3000 and Russell 2000 indexes

2024-06-18 08:43:02 ET More on Aquestive Therapeutics Aquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024 Aquestive stock falls amid Libervant approval, Anaphylm update Aquestive wins FDA approval for anti-seizure therapy Libervant ...

AQST - Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technolog...

AQST - Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities

Sherry Korczynski joins the leadership team as Senior Vice President, Sales and Marketing Dr. Stephen Wargacki promoted to Chief Science Officer Cassie Jung named Chief Operating Officer WARREN, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ...
AQST - Aquestive Therapeutics to Present Anaphylm(TM) (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference

WARREN, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologi...

AQST - CRSP, NYMT and SBRA are among after hour movers

2024-05-17 17:05:06 ET Gainers: Stronghold Digital Mining ( SDIG ) +7% . New York Mortgage Trust ( NYMT ) +3% . Outbrain  ( OB ) +3% . Aquestive Therapeutics ( AQST ) +2% . Airship AI Holdings ( AISP ) +2% . Losers: ...

AQST - Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference

WARREN, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participa...
Next 10